Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Why biotechs can benefit from the 'rational' IPO environment
2024 saw a healthier IPO market than 2023, with activity triggered by M&A that occurred in the back end of '23, Morgan Stanley's Chirag Surti said.
Gabrielle Masson
Jan 24, 2025 10:30am
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M debut
Jan 24, 2025 5:02am
GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO
Jan 23, 2025 8:01am
BMS, Takeda's Chinese partners file for IPOs
Jan 22, 2025 6:11am
Odyssey, Sionna join band of biotechs braving the IPO waters
Jan 21, 2025 5:27am
Obesity biotech Metsera files for a swift IPO
Jan 11, 2025 9:05am
